
Curasis Lifesciences Private Limited
About Curasis Lifesciences Private Limited
Data last updated:
Curasis Lifesciences Private Limited is a private limited company based in Bhopal, Madhya Pradesh, India. It was incorporated on 22 May 2023.
The company is registered with the Registrar of Companies (ROC), Gwalior, under CIN U46497MP2023PTC065877. Its GSTIN is 23AALCC0521A1ZJ (Madhya Pradesh).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajeev Singh Singroul and Sachendra Dubey.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Bhopal, Madhya Pradesh.
As per the financials filed for FY 2025, the company reported a revenue of ₹21.29 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1,150 (net margin -0.1%) and EBITDA of -₹1,150 (EBITDA margin -0.1%).
Company details
Contact details
Curasis Lifesciences Private Limited's registered office is in Bhopal, Madhya Pradesh.
- Registered AddressF No 302 Block Jasper, Siddhi Saffron Sankhedi, Bhopal, Madhya Pradesh, India – 462042
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Curasis Lifesciences is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Curasis Lifesciences Private Limited, buy the company report.
Financials of Curasis Lifesciences Private Limited
FY 2025 filings availableCurasis Lifesciences Private Limited reported revenue of ₹21.29 Lakh (up 241% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue rose 241% in the latest year. EBITDA rose 79% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | -₹1,150 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹1,150 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | -0.1% | |
| Net Profit Margin | -0.1% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Curasis Lifesciences Private Limited, buy the company report.
Board of directors of Curasis Lifesciences Private Limited
Curasis Lifesciences has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajeev Singh Singroul | Director | 22 May 2023 | 3 Years 5 Months | Current |
| Sachendra Dubey | Director | 22 May 2023 | 3 Years 5 Months | Current |
Peer comparison
Curasis Lifesciences Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Lifesciences), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Wellmaxx Lifesciences Private Limited | ₹22.52 Lakh (FY 2024) | 40.0% | Kanpur Deaht, Uttar Pradesh, India | |||
| Medipathy Lifesciences Private Limited | ₹21.79 Lakh (FY 2025) | -5.0% | Delhi, India | |||
| Curasis Lifesciences Private Limitedthis company | ₹21.29 Lakh (FY 2025) | -₹1,150 | -0.1% | 241.0% | Bhopal, Madhya Pradesh, India | |
| Sysmed Lifesciences Private Limited | ₹21.16 Lakh (FY 2025) | 6.0% | Dasna Ghaziabad, Uttar Pradesh, India | |||
| Raptron Lifesciences Private Limited | ₹20.57 Lakh (FY 2025) | 94.0% | Bhopal, Madhya Pradesh, India |
To see the full peer comparison of Curasis Lifesciences Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Curasis Lifesciences Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Curasis Lifesciences Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Curasis Lifesciences has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 23AALCC0521A1ZJ | Madhya Pradesh | Active | 06 Sep 2023 |
To see the full GST registrations and return filing status of Curasis Lifesciences Private Limited, buy the company report.
Recent activity
Curasis Lifesciences Private Limited has 2 board changes on record since 2023: 2 appointments. The latest: Rajeev Singh Singroul was appointed as Director on 22 May 2023.
Frequently asked questions
Curasis Lifesciences is an active private limited company based in Bhopal, Madhya Pradesh, India. It was incorporated on 22 May 2023 (3+ years old) and is registered under CIN U46497MP2023PTC065877.
Curasis Lifesciences has 2 current directors:
- Rajeev Singh Singroul - Director
- Sachendra Dubey - Director
The latest financial statements of Curasis Lifesciences on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2024 are in the company report.
The GSTIN of Curasis Lifesciences is 23AALCC0521A1ZJ, registered in Madhya Pradesh.
The CIN (Corporate Identification Number) of Curasis Lifesciences is U46497MP2023PTC065877. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Curasis Lifesciences was incorporated on 22 May 2023, making it 3+ years old. It is registered with the Registrar of Companies, Gwalior.
The peers of Curasis Lifesciences by revenue are Wellmaxx Lifesciences Private Limited, Medipathy Lifesciences Private Limited, Sysmed Lifesciences Private Limited, Raptron Lifesciences Private Limited, all in the Pharma industry (Lifesciences), with the same principal business activity (wholesale trading).
Rajeev Singh Singroul was appointed as Director on 22 May 2023. Sachendra Dubey was appointed as Director on 22 May 2023.
The registered office of Curasis Lifesciences is at F No 302 Block Jasper, Siddhi Saffron Sankhedi, Bhopal, Madhya Pradesh, India – 462042.
Curasis Lifesciences can be reached at its registered office: F No 302 Block Jasper, Siddhi Saffron Sankhedi, Bhopal, Madhya Pradesh, India – 462042.
Curasis Lifesciences is registered under the jurisdiction of the Registrar of Companies (ROC), Gwalior.

